organization · Reporting owner
Prime Movers Lab Fund I LP
Disclosed activity across 3 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Heliogen, Inc.HLGN · Entity 78373 | 10% owner | June 12, 2023 | June 14, 2023 |
| Momentus Inc.MNTS · Entity 6834 | 10% owner | September 22, 2023 | September 26, 2023 |
| Vaxxinity, Inc.VAXX · Entity 91688 | 10% owner | September 06, 2023 | September 08, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Heliogen, Inc.
Report date June 12, 2023 · Filed June 14, 2023
Jointly reported with Sloss Dakin, Heliogen PML SPV 1 LP, Prime Movers Lab GP I LLC, Prime Movers Lab GP II LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Lab Fund I LP | 10,477,320 |
Last balance in matching sequence
After 2023-06-13 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-06-12 · Sale · Disposed 275,000 · Balance 13,402,320 F4: The price of $0.2035 per share represents a weighted average of purchase prices ranging from $0.1985 to $0.2231 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 2 · 2023-06-13 · Sale · Disposed 2,925,000 · Balance 10,477,320 F5: The price of $0.1997 per share represents a weighted average of purchase prices ranging from $0.1910 to $0.2101 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Heliogen PML SPV 1 LP | 6,668,457 |
Reported balance
Holding disclosure · report date 2023-06-12 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 6,668,457 F2: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML. F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML.
F2: Held by Heliogen PML SPV 1 LP ("Heliogen PML"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of Heliogen PML.
F3: Dakin Sloss is the manager of PML GP and PML GP II and as a result may be deemed to have or share beneficial ownership the securities held by PML and Heliogen PML. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F4: The price of $0.2035 per share represents a weighted average of purchase prices ranging from $0.1985 to $0.2231 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F5: The price of $0.1997 per share represents a weighted average of purchase prices ranging from $0.1910 to $0.2101 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Momentus Inc.
Report date September 22, 2023 · Filed September 26, 2023
Jointly reported with Sloss Dakin, Prime Movers Growth Fund I LP, Momentus PML SPV 1 LP, MOMENTUS PML SPV 2 LP, Momentus PML SPV 3 LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stockSEC Table I · non-derivative | Direct | 77,837 |
Last balance in matching sequence
After 2023-09-25 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-09-22 · Sale · Disposed 13,574 · Balance 109,098 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 6 · 2023-09-25 · Sale · Disposed 31,261 · Balance 77,837 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 1 LP | 30,853 |
Last balance in matching sequence
After 2023-09-25 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2023-09-22 · Sale · Disposed 5,381 · Balance 43,245 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 7 · 2023-09-25 · Sale · Disposed 12,392 · Balance 30,853 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 2 LP | 8,520 |
Reported balance
After 2023-09-22 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2023-09-22 · Sale · Disposed 1,060 · Balance 8,520 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 3 LP | 21,133 |
Reported balance
After 2023-09-22 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2023-09-22 · Sale · Disposed 2,630 · Balance 21,133 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund I LP | 8,418 |
Reported balance
After 2023-09-22 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2023-09-22 · Sale · Disposed 1,048 · Balance 8,418 F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 2 LP | 4,734 |
Last balance in matching sequence
After 2023-09-26 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 8 · 2023-09-25 · Sale · Disposed 2,442 · Balance 6,078 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 13 · 2023-09-26 · Sale · Disposed 1,344 · Balance 4,734 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 3 LP | 11,745 |
Last balance in matching sequence
After 2023-09-26 transaction · row 14
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 9 · 2023-09-25 · Sale · Disposed 6,056 · Balance 15,077 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 14 · 2023-09-26 · Sale · Disposed 3,332 · Balance 11,745 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund I LP | 4,679 |
Last balance in matching sequence
After 2023-09-26 transaction · row 15
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 10 · 2023-09-25 · Sale · Disposed 2,412 · Balance 6,006 F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 15 · 2023-09-26 · Sale · Disposed 1,327 · Balance 4,679 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 60,635 |
Reported balance
After 2023-09-26 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2023-09-26 · Sale · Disposed 17,202 · Balance 60,635 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Momentus PML SPV 1 LP | 24,034 |
Reported balance
After 2023-09-26 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2023-09-26 · Sale · Disposed 6,819 · Balance 24,034 F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1. F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Prime Movers Lab Fund I LP ("PML"). Prime Movers Lab GP I LLC ("PML GP") is the general partner of PML.
F2: Held by Momentus PML SPV 1 LP ("PML SPV 1"). PML GP is the general partner of PML SPV 1.
F3: Held by Momentus PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F4: Held by Momentus PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F5: Held by Prime Movers Growth Fund I LP ("PM Growth"). Prime Movers Growth GP I LLC ("PM Growth GP") is the general partner of PM Growth.
F6: Dakin Sloss is the manager of PML GP, PML GP II and PM Growth GP, and may be deemed to beneficially own the securities held by PML, PML SPV 1, PML SPV 2, PML SPV 3 and PM Growth. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F7: The price of $2.3862 per share represents a weighted average of purchase prices ranging from $2.26 to $2.76 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F8: The price of $2.0445 per share represents a weighted average of purchase prices ranging from $1.87 to $2.39 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F9: The price of $1.9127 per share represents a weighted average of purchase prices ranging from $1.76 to $2.01 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Vaxxinity, Inc.
Report date September 06, 2023 · Filed September 08, 2023
Jointly reported with Sloss Dakin
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 1 LP | 2,058,990 |
Last balance in matching sequence
After 2023-09-07 transaction · row 6
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-09-06 · Sale · Disposed 1,251 · Balance 2,063,776 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 6 · 2023-09-07 · Sale · Disposed 4,786 · Balance 2,058,990 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | Direct | 8,738,752 |
Last balance in matching sequence
After 2023-09-07 transaction · row 7
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 2 · 2023-09-06 · Sale · Disposed 5,308 · Balance 8,759,064 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 7 · 2023-09-07 · Sale · Disposed 20,312 · Balance 8,738,752 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 2 LP | 831,658 |
Last balance in matching sequence
After 2023-09-08 transaction · row 13
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 3 · 2023-09-06 · Sale · Disposed 507 · Balance 835,992 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 8 · 2023-09-07 · Sale · Disposed 1,939 · Balance 834,053 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 13 · 2023-09-08 · Sale · Disposed 2,395 · Balance 831,658 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 3 LP | 1,472,208 |
Reported balance
After 2023-09-06 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2023-09-06 · Sale · Disposed 892 · Balance 1,472,208 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund 1 LP | 3,612,849 |
Reported balance
After 2023-09-06 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2023-09-06 · Sale · Disposed 2,189 · Balance 3,612,849 F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 3 LP | 1,464,578 |
Last balance in matching sequence
After 2023-09-08 transaction · row 14
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 9 · 2023-09-07 · Sale · Disposed 3,413 · Balance 1,468,795 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 14 · 2023-09-08 · Sale · Disposed 4,217 · Balance 1,464,578 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by Prime Movers Growth Fund 1 LP | 3,594,122 |
Last balance in matching sequence
After 2023-09-08 transaction · row 15
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 10 · 2023-09-07 · Sale · Disposed 8,378 · Balance 3,604,471 F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Row 15 · 2023-09-08 · Sale · Disposed 10,349 · Balance 3,594,122 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectHeld by COVAXX PML SPV 1 LP | 2,053,079 |
Reported balance
After 2023-09-08 transaction · row 11
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 11 · 2023-09-08 · Sale · Disposed 5,911 · Balance 2,053,079 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | Direct | 8,713,663 |
Reported balance
After 2023-09-08 transaction · row 12
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 12 · 2023-09-08 · Sale · Disposed 25,089 · Balance 8,713,663 F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. F3: Held by PML. PML GP I is the general partner of PML. F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: The price of $1.8823 per share represents a weighted average of purchase prices ranging from $1.85 to $1.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1.
F3: Held by PML. PML GP I is the general partner of PML.
F4: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2.
F5: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3.
F6: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG.
F7: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein.
F8: The price of $1.7872 per share represents a weighted average of purchase prices ranging from $1.75 to $1.86 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F9: The price of $1.6700 per share represents a weighted average of purchase prices ranging from $1.60 to $1.82 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 15, 2021 Filed Nov 15, 2021 16:24 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | ConversionClass A common stock | 9,738,192 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001446 · edgar.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,738,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. F6 · ownership.direct: Held by PML. PML GP I is the general partner of PML. F7 · ownership.direct: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 16:24 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | ConversionClass A common stock | 3,615,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001446 · edgar.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Prime Movers Growth Fund 1 LP Disclosed balance after: 3,615,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. F5 · ownership.nature: Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 16:24 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | ConversionClass A common stock | 1,517,754 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001446 · edgar.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 3 LP Disclosed balance after: 1,517,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. F4 · ownership.nature: Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 16:24 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | ConversionClass A common stock | 861,857 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001446 · edgar.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 2 LP Disclosed balance after: 861,857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. F3 · ownership.nature: Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| November 15, 2021 Filed Nov 15, 2021 16:24 UTC | Vaxxinity, Inc. VAXX · Entity 91688 | ConversionClass A common stock | 2,294,473 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001123292-21-001446 · edgar.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by COVAXX PML SPV 1 LP Disclosed balance after: 2,294,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. F2 · ownership.nature: Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. F7 · ownership.nature: Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantWarrants (right to buy) · Derivative | 1,000,000 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · derivative · entry 6 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires not disclosed F4 · price: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F4 · derivative.exercise_date: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F4 · derivative.expiration_date: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 2,526,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 3 LP Disclosed balance after: 2,526,394 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 1,018,594 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 2 LP Disclosed balance after: 1,018,594 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 6,373,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 1 LP Disclosed balance after: 6,373,200 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,905,597 F3 · price: Pursuant to a Subscription Agreement dated as of July 16, 2021 (as amended from time to time, the "Subscription Agreement") entered into in connection with the Business Combination Agreement, the Reporting Person agreed to subscribe for and purchase, in a private placement immediately prior to the closing of the Business Combination, an aggregate of 1,000,000 shares of Class A Common Stock of the Issuer for a purchase price of $10.00 per share. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Aug 16, 2021 21:08 UTC | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 14,905,597 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-051731 · doc4.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,905,597 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantWarrants (right to buy) · Derivative | 1,000,000 | Not disclosed Strike: $11.50 | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · derivative · entry 6 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Class A Common Stock · 1,000,000 shares Expires not disclosed F4 · price: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F4 · derivative.exercise_date: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F4 · derivative.expiration_date: Pursuant to the Subscription Agreement, the Reporting Person received a warrant to purchase one share of Class A Common Stock of the Issuer at a price of $11.50 per share (subject to adjustment as described in the warrant agreement) for each share of Class A Common Stock of the Issuer purchased by the Reporting Person. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 2,526,394 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · nonDerivative · entry 5 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 3 LP Disclosed balance after: 2,526,394 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 1,018,594 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · nonDerivative · entry 4 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 2 LP Disclosed balance after: 1,018,594 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 6,373,200 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · nonDerivative · entry 3 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Momentus PML SPV 1 LP Disclosed balance after: 6,373,200 F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F2 · ownership.nature: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · nonDerivative · entry 2 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,078,460 F3 · price: Pursuant to a Subscription Agreement dated as of July 16, 2021 (as amended from time to time, the "Subscription Agreement") entered into in connection with the Business Combination Agreement, the Reporting Person agreed to subscribe for and purchase, in a private placement immediately prior to the closing of the Business Combination, an aggregate of 1,000,000 shares of Class A Common Stock of the Issuer for a purchase price of $10.00 per share. F6 · balance_after: The amount of securities beneficially owned following the reported transaction has been adjusted to correct for a previous clerical error. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
| August 12, 2021 Filed Feb 18, 2022 17:33 UTC Amendment | Momentus Inc. MNTS · Entity 6834 | GrantClass A Common Stock | 15,078,460 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-22-005000 · form4a.xml · nonDerivative · entry 1 Prime Movers Lab Fund I LP · CIK 0001751631 · 10% owner Momentus PML SPV 1 LP · CIK 0001780632 · 10% owner MOMENTUS PML SPV 2 LP · CIK 0001819327 · 10% owner Momentus PML SPV 3 LP · CIK 0001853076 · 10% owner Sloss Dakin · CIK 0001875411 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,078,460 F5 · date: This amendment is being filed to correct a clerical error in the number of securities acquired and to correct a technical error that caused the omission of Dakin Sloss as a reporting person. F1 · price: On August 12, 2021, pursuant to that certain Agreement and Plan of Merger, dated as of October 7, 2020 (as amended, supplemented or modified from time to time, the "Merger Agreement"), by and among Stable Road Acquisition Corp., a Delaware corporation (the "Issuer"), Momentus Inc., a Delaware corporation ("Legacy Momentus"), and the other parties thereto, the Issuer completed its initial business combination (the "Business Combination"). As a result of the Business Combination, the Issuer changed its name to Momentus Inc. In connection with the Business Combination and in accordance with the Merger Agreement, an aggregate of 65,133,131 shares of Class A Common Stock of Legacy Momentus held by the Reporting Person were converted into 14,905,597 shares of Class A Common Stock of the Issuer. The issuance of the shares was approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended. F6 · balance_after: The amount of securities beneficially owned following the reported transaction has been adjusted to correct for a previous clerical error. F2 · ownership.direct: Prime Movers Lab GP I LLC is the general partner of each of the Reporting Persons. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.